查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542921

全球骨蠟市場 - 2024-2031

Global Bone Wax Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球骨蠟市場在2023年達到6,560萬美元，預計到2031年將達到8,200萬美元，在2024-2031年預測期間複合年成長率為2.8%。

骨蠟是一種無菌外科產品，常用於骨科、神經外科和胸腔外科。它由蜂蠟和凡士林的混合物組成，有時還會添加棕櫚酸異丙酯或羊毛脂等物質。骨蠟用途廣泛，可以應用於各種骨骼表面，包括那些不規則或有小缺陷的骨骼表面。其柔韌的特性使其易於成型和應用，適用於各種手術場景。

骨蠟多年來一直是外科手術的標準工具，具有良好的安全性和有效性記錄。它在不同外科專業的廣泛使用以及被納入標準外科手術方案中凸顯了其重要性。骨蠟使外科醫生能夠在乾淨、無血的環境中工作，從而提高手術精度。這種清晰度增強了手術部位的可視性，使外科醫生能夠更準確和自信地執行精細的手術。

市場動態：

促進因素和限制因素

運動和娛樂相關傷害的發生率不斷上升

運動和娛樂相關的損傷通常會導致骨折，特別是承重骨，如脛骨、腓骨和股骨。在骨折修復手術中，骨蠟經常用於控制骨表面出血，特別是在有嚴重軟組織創傷的情況下。運動傷害導致骨折發生率的增加與骨蠟的需求直接相關。

例如，根據約翰霍普金斯大學2022年發表的文章估計，在美國，約有3000萬兒童和青少年參加某種形式的有組織的體育運動，每年有超過350萬人受傷，導致參與時間的損失，由參與者體驗。兒童期發生的所有傷害中幾乎有三分之一是與運動相關的傷害。

此外，根據韋恩斯坦法律團隊2020年3月發布的報告稱，美國每年有近3,000萬名兒童和青少年參與青少年運動。這可能會導致骨科緊急情況，從而導致對手術和骨蠟的需求，從而推動市場成長。此外，運動傷害可能導致需要手術介入的複雜創傷，例如多發性骨折、脫位和骨骼畸形。

市場動態：

克制

替代止血劑的出現

合成密封劑、止血凝膠和先進止血粉末等替代止血劑的開發可能對骨蠟市場的成長構成挑戰。外科醫生可能會選擇這些較新的產品而不是傳統的骨蠟，特別是在需要快速止血或生物分解性等特定性能的情況下。

替代止血劑在特定特性方面可能比骨蠟更具優勢，例如快速止血、易於使用、可生物分解性或增強的安全性。例如，Baxter產品如Ostene骨止血材料是骨蠟的替代品。此外，新型止血劑可能會經過嚴格的測試和臨床評估以獲得監管部門的批准，確保符合安全性和有效性標準。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：市場動態

  • 影響因素
    • 促進要素
      • 運動和娛樂相關傷害的發生率不斷上升
      • 產品技術不斷進步
  • 限制
    • 替代止血劑的出現
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 未滿足的需求
  • DMI 意見

第 6 章：COVID-19 分析

第 7 章：依產品

  • 可吸收骨蠟
  • 不可吸收的骨蠟

第 8 章：按材料

  • 天然骨蠟
  • 合成骨蠟

第 9 章：按申請

  • 胸腔外科
  • 骨科手術
  • 牙科/口腔外科
  • 神經外科
  • 其他

第 10 章：最終用戶

  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

第 11 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 12 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • B. Braun SE
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Cura Medical
  • Dolphin Sutures
  • GPC Medical Ltd
  • Abyrx Inc
  • Bentley Healthcare Pvt. Ltd.
  • Medtronic Plc
  • Ethicon, Inc
  • Medline Industries, Inc
  • CORMEDICA (LIST NOT EXHAUSTIVE

第 14 章：附錄

簡介目錄
Product Code: MD1268

Market Overview

The Global Bone Wax Market reached US$ 65.60 million in 2023 and is expected to reach US$ 82.00 million by 2031, growing at a CAGR of 2.8% during the forecast period 2024-2031.

Bone wax is a sterile surgical product commonly used in orthopedic, neurosurgical, and thoracic surgeries. It is composed of a mixture of beeswax and petroleum jelly, sometimes with added substances like isopropyl palmitate or lanolin. Bone wax is versatile and can be applied to various bone surfaces, including those with irregularities or small defects. Its pliable nature allows for easy molding and application, making it suitable for a wide range of surgical scenarios.

Bone wax has been a standard tool in surgical practice for many years, with a proven track record of safety and efficacy. Its importance is underscored by its widespread use across different surgical specialties and its inclusion in standard surgical protocols. Bone wax facilitates surgical precision by allowing surgeons to work in a clear and blood-free environment. This clarity enhances visibility of the surgical site, enabling surgeons to perform delicate procedures with greater accuracy and confidence.

Market Dynamics: Drivers and Restraints

Increasing prevalence of sports and recreation-related injuries

Sports and recreation-related injuries often result in fractures, particularly in weight-bearing bones such as the tibia, fibula, and femur. During fracture repair surgeries, bone wax is frequently used to control bleeding from bone surfaces, especially in cases where significant soft tissue trauma is present. The increasing incidence of fractures due to sports injuries directly correlates with the demand for bone wax.

For instance, according to article published in Johns Hopkins University 2022, estimated that, in U.S., about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year, which cause some loss of time of participation, are experienced by the participants. Almost one-third of all injuries incurred in childhood are sports-related injuries.

Additionally, according to a Weinstein Legal Team report published in March 2020, stated that, nearly 30 million children and adolescents participate in youth sports in U.S. each year. This can lead to orthopedic emergencies leading to a demand for surgeries and bone wax, thus driving the market growth. Moreover, sports injuries can result in complex trauma requiring surgical intervention, such as multiple fractures, dislocations, and bone deformities.

Market Dynamics: Restraint

Emergence of alternative hemostatic agents

The development of alternative hemostatic agents, such as synthetic sealants, hemostatic gels, and advanced hemostatic powders, may pose a challenge to the growth of the bone wax market. Surgeons may opt for these newer products over traditional bone wax, particularly in cases where specific properties like rapid hemostasis or biodegradability are desired.

Alternative hemostatic agents may offer advantages over bone wax in terms of specific properties such as rapid hemostasis, ease of use, biodegradability, or enhanced safety profiles. For instance, Baxter products like Ostene bone hemostasis material is alternative to bone wax. Additionally, newer hemostatic agents may undergo rigorous testing and clinical evaluation to obtain regulatory approval, ensuring compliance with safety and efficacy standards.

Segment Analysis

The global bone wax market is segmented based on product, material, application, end-user and region.

The absorbable bone wax from the product segment accounted for approximately 61.43% of share

There is an increasing demand for biodegradable medical products across various surgical procedures. Absorbable bone wax falls into this category, as it offers the benefits of traditional bone wax without the need for removal post-surgery. For instance, innovations in material science have led to the development of absorbable bone wax made from biocompatible materials such as polysaccharides or synthetic polymers.

These materials offer effective hemostasis while being gradually absorbed by the body, eliminating the need for a secondary surgical procedure for removal. Additionally, absorbable bone wax eliminates the risks associated with traditional bone wax, such as the potential for infection or foreign body reactions. Surgeons find it convenient to use absorbable bone wax, as it simplifies the surgical process and reduces the need for additional interventions.

While absorbable bone wax may have a higher upfront cost compared to traditional bone wax, its absorbable nature eliminates the need for a second surgical procedure for removal. This can lead to cost savings for healthcare providers and patients in the long run. Thus above factors helps to boost the segment growth.

Geographical Analysis

North America accounted for approximately 39.37% of the market share in 2023

North America, particularly the United States and Canada, boasts advanced healthcare infrastructure with a high level of access to medical facilities and surgical procedures. This infrastructure supports the adoption of advanced medical technologies, including bone wax, in surgical settings.

North America experiences a high volume of surgical procedures across various specialties, including orthopedic, neurological, and cardiovascular surgeries. For instance, according to Cleveland Clinic 2022, a sternotomy procedure is very common. It's the approach cardiac surgeon's use most often for coronary artery bypass surgery and other heart surgeries. Surgeons perform more than 700,000 sternotomies each year in the United States.

Additionally, United States, in particular, has one of the highest healthcare expenditures globally. This substantial healthcare spending creates a conducive environment for the adoption of advanced medical technologies, including bone wax, in surgical practice. Thus, above factors help to boost the region growth.

COVID-19 Impact Analysis

While elective surgeries declined, there was an increased focus on emergency and life-saving procedures, including certain cardiovascular surgeries. Bone wax continued to be essential in these emergency surgeries to control bleeding and facilitate wound closure. The pandemic underscored the importance of infection control measures in healthcare settings.

Surgeons and healthcare facilities may have become more vigilant about using sterile surgical products, including bone wax, to minimize the risk of surgical site infections and other complications. To reduce the risk of virus exposure and conserve resources, there was a trend towards performing minimally invasive procedures when possible.

While bone wax is primarily used in open surgeries like sternotomy, the overall shift towards minimally invasive techniques could have affected the demand for traditional bone wax. As vaccination efforts expanded and healthcare systems adapted to the pandemic, many regions experienced a gradual recovery in elective surgeries. This likely led to a rebound in demand for bone wax and other surgical products as surgical volumes returned to pre-pandemic levels.

Competitive Landscape

The major global players in the market include B. Braun SE, Cura Medical, Dolphin Sutures, GPC Medical Ltd, Abyrx Inc, Bentley Healthcare Pvt. Ltd., Medtronic Plc, Ethicon, Inc, Medline Industries, Inc, CORMEDICA, among others.

Why Purchase the Report?

To visualize the global bone wax market segmentation based on product, material, application, end-user and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of bone wax market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global bone wax market report would provide approximately 69 tables, 58 figures and 187 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Material
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Market Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of sports and recreation-related injuries
      • 4.1.1.2. Rising technological advancements of the products
  • 4.2. Restraints
    • 4.2.1. Emergence of alternative hemostatic agents
    • 4.2.2. Opportunity
    • 4.2.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Absorbable Bone Wax *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Non-absorbable Bone Wax

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.1.2. Market Attractiveness Index, By Material
  • 8.2. Natural Bone Wax *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Synthetic Bone Wax

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Thoracic Surgery *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Orthopedic Surgery
  • 9.4. Dental/Oral Surgery
  • 9.5. Neurosurgery
  • 9.6. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Specialty Clinics
  • 10.4. Ambulatory Surgical Centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. South Korea
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. B. Braun SE *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Cura Medical
  • 13.3. Dolphin Sutures
  • 13.4. GPC Medical Ltd
  • 13.5. Abyrx Inc
  • 13.6. Bentley Healthcare Pvt. Ltd.
  • 13.7. Medtronic Plc
  • 13.8. Ethicon, Inc
  • 13.9. Medline Industries, Inc
  • 13.10. CORMEDICA (LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us